Baidu
map

Nature Communications连续发表我国科学家银屑病易感基因研究成果

2015-04-24 生物谷 生物谷

安徽医科大学皮肤病研究所皮肤遗传学研究团队在国家自然科学基金面上、重点、国际合作项目、教育部皮肤病遗传学创新团队项目、疑难重症皮肤病协同创新中心等项目的资助下,最新研究成果"全外显子组研究鉴定出15个新的银屑病易感位点"(Whole exome analysis SNP array identifies 15 new psoriasis susceptibility loci for pso

安徽医科大学皮肤病研究所皮肤遗传学研究团队在国家自然科学基金面上、重点、国际合作项目、教育部皮肤病遗传学创新团队项目、疑难重症皮肤病协同创新中心等项目的资助下,最新研究成果"全外显子组研究鉴定出15个新的银屑病易感位点"(Whole exome analysis SNP array identifies 15 new psoriasis susceptibility loci for psoriasis)和全基因组meta分析发现多个新的银屑病易感基因及揭示种族异质性(Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility)分别于4月9日和23日在国际著名期刊Nature Communications在线发表。

银屑病是一种常见的反复发作、以表皮增殖和炎症为特征的免疫相关性皮肤病,严重影响患者健康和生活质量。遗传因素在银屑病发病中起重要作用,全基因组关联研究(Genome Wide Association Study, GWAS)已发现银屑病40多个易感基因,极大推进了银屑病遗传学研究进程。不同人群银屑病GWAS的meta分析进一步验证了之前研究结果的真实性,并且能够探明银屑病的易感性在不同人群中存在遗传异质性。外显子芯片(Exome BeadChip)技术覆盖了推定的功能性外显子变异,这些变异精选自12,000多个个体的外显子组和全基因组序列,代表了不同群体多种常见病,成功弥补了GWAS的在发现与疾病直接相关的外显子区编码遗传变异即直接改变蛋白结构和功能的致病变异上的不足。

近年来,安徽医科大学皮肤病研究所再次联合中国、美国、新加坡、瑞典、加拿大、德国、西班牙等多种族人群共计15369病例和19517对照开展银屑病GWAS的Meta分析,发现4个银屑病相关联的易感基因LOC144817、COG6、RUNX1和TP63,以及位于IFIH1 和IL12B基因上的3个提示易感位点。MHC区域精确定位分析发现HLA-I区域3个基因均与银屑病相关联,并且在加拿大人群和中国人群中存在异质性。种族迁移比较分析表明11个位点存在人群特殊效应和等位基因异质性。研究成果发表在Natrue Communications上,该文第一作者尹先勇博士说道:本研究不仅为银屑病的发病机制提供了新的生物学角度,而且通过人群分析进一步证实了银屑病遗传异质性,对研发药物及个体化医疗具有指导意义。

为探索基因功能性编码变异在银屑病遗传学发病机制上的作用,安徽医科大学皮肤病研究所遗传学研究团队,通过对3个独立汉族人群(包括42,760例样本)进行外显子芯片研究,发现23个遗传变异(16个编码变异和7个非编码变异)与银屑病显着相关,这些易感变异分别位于15个新的银屑病易感基因(C1orf141、ZNF683、TMC6、AIM2、IL1RL1、CASR、SON、ZFYVE16、MTHFR、CCDC129、ZNF143、AP5B1、SYNE2和 IFNGR2)和4个既往GWAS研究已报道易感基因(TNIP1、NFKBIA、IL12B和LCE3D-LCE3E基因)。此外,通过蛋白质功能预测发现位于AIM2基因上的编码变异可能会影响该基因编码的蛋白质的结构,从而引起生物学功能上的改变。研究成果发表在Nature Communications上,该文第一作者左先波副教授提到:通过外显子芯片技术,有望找到银屑病发病直接相关的功能性变异,与传统银屑病GWAS研究形成优势互补,从而全面揭示银屑病的遗传学发病机制,为银屑病药物靶点研发、疾病预防与诊疗提供新的契机,为实现银屑病的精准医学奠定坚实基础。

据悉,安徽医科大学皮肤病研究所在银屑病遗传学研究方面一直处于世界领先地位,在国际知名期刊上发表了一系列原创性科研成果。该团队于2008年利用全基因组关联研究(我国首个全基因组关联分析研究),成功发现控制银屑病表皮角质形成细胞角化过程的易感基因LCE,研究成果发表在国际著名期刊Nature Genetics(Nature Genetics, 2009)。2010年作为牵头单位领衔中国、德国和美国多家单位开展银屑病GWAS联合分析,发现6个新的银屑病易感基因和遗传异质性(Nature Genetics, 2010)。2013年采用二代测序技术发现银屑病3个新的易感基因(Nature Communications, 2014);2014年利用全基因组外显子测序和靶向基因测序,发现GWAS鉴定的银屑病易感基因中7个基因存在编码变异。(Nature Genetics, 2014)。这些研究极大的推动了银屑病病因学研究进程,阐释了银屑病发病的遗传机制,为银屑病的预防提供了依据,风险预测提供了生物学标记,治疗提供新的靶点,具有明显应用前景,产生了重要国际影响。

原始出处:

Xianbo Zuo,Liangdan Sun,Xianyong Yin et al.Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis.Nature Communications, April 9, 2015; doi:10.1038/ncomms7793

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1898383, encodeId=c89e1898383e4, content=<a href='/topic/show?id=0bdfe3394a4' target=_blank style='color:#2F92EE;'>#研究成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73394, encryptionId=0bdfe3394a4, topicName=研究成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Tue Apr 05 19:13:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086783, encodeId=1e802086e8328, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 03 09:13:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880612, encodeId=61311880612c7, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 11 18:13:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394428, encodeId=4cf3139442808, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573389, encodeId=101c15e3389fd, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1898383, encodeId=c89e1898383e4, content=<a href='/topic/show?id=0bdfe3394a4' target=_blank style='color:#2F92EE;'>#研究成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73394, encryptionId=0bdfe3394a4, topicName=研究成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Tue Apr 05 19:13:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086783, encodeId=1e802086e8328, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 03 09:13:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880612, encodeId=61311880612c7, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 11 18:13:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394428, encodeId=4cf3139442808, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573389, encodeId=101c15e3389fd, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=)]
    2015-11-03 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1898383, encodeId=c89e1898383e4, content=<a href='/topic/show?id=0bdfe3394a4' target=_blank style='color:#2F92EE;'>#研究成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73394, encryptionId=0bdfe3394a4, topicName=研究成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Tue Apr 05 19:13:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086783, encodeId=1e802086e8328, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 03 09:13:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880612, encodeId=61311880612c7, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 11 18:13:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394428, encodeId=4cf3139442808, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573389, encodeId=101c15e3389fd, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=)]
    2015-05-11 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1898383, encodeId=c89e1898383e4, content=<a href='/topic/show?id=0bdfe3394a4' target=_blank style='color:#2F92EE;'>#研究成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73394, encryptionId=0bdfe3394a4, topicName=研究成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Tue Apr 05 19:13:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086783, encodeId=1e802086e8328, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 03 09:13:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880612, encodeId=61311880612c7, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 11 18:13:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394428, encodeId=4cf3139442808, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573389, encodeId=101c15e3389fd, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1898383, encodeId=c89e1898383e4, content=<a href='/topic/show?id=0bdfe3394a4' target=_blank style='color:#2F92EE;'>#研究成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73394, encryptionId=0bdfe3394a4, topicName=研究成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Tue Apr 05 19:13:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086783, encodeId=1e802086e8328, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 03 09:13:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880612, encodeId=61311880612c7, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 11 18:13:00 CST 2015, time=2015-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394428, encodeId=4cf3139442808, content=<a href='/topic/show?id=7deb59659b9' target=_blank style='color:#2F92EE;'>#易感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59659, encryptionId=7deb59659b9, topicName=易感基因)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/72D57F5B3E12B2BB53D6BD015D14DCD6/100, createdBy=a92e2500162, createdName=passed water, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1573389, encodeId=101c15e3389fd, content=<a href='/topic/show?id=28f4125430b' target=_blank style='color:#2F92EE;'>#Nature Communications#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12543, encryptionId=28f4125430b, topicName=Nature Communications)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bea15872676, createdName=qindq, createdTime=Sun Apr 26 00:13:00 CST 2015, time=2015-04-26, status=1, ipAttribution=)]

相关资讯

Otezla可能被欧盟批准用于斑块型银屑病治疗

生物技术巨头新基(Celgene)重磅药物Otezla(apremilast)近日在欧盟监管方面收获好消息,欧洲药品管理局(EMA)人用医药产品委员会(CHMP)已建议批准Otezla,用于2种适应症。欧盟委员会(EC)通常都会采纳CHMP的意见,这意味着Otezla将在未来2-3个月在欧盟获批上市。 在美国,FDA分别于2014年3月和9月批准Otezla用于活动性银屑病关节炎(PsA)及中度

斑块性银屑病新药brodalumab临床III期结果优异

治疗斑块性银屑病药物brodalumab在临床三期对比研究中击败了畅销药物Stelara。这一研究结果也将有利于brodalumab在欧盟和美国市场的药物审批过程。 根据公司披露的数据,此次临床三期研究主要采用了Psoriasis Area and Severity Index score 100(PASI 100)和Psoriasis Area and Severity Index score

Nat Commun:银屑病3个新的易感基因位点被发现

来自安徽医科大学、复旦大学附属华山医院、华大基因研究院等处的研究人员,通过基于测序的方法鉴别出了3个新的银屑病易感基因位点。相关论文发表在7月9日的《自然通讯》(Nature Communications)杂志上。 安徽医科大学的张学军(Xuejun Zhang)教授、孙良丹(Liangdan Sun)副教授和香港中文大学的徐雷(Lei Xu)教授是这篇论文的共同通讯作者。 银屑病俗称牛皮癣,

GSK与Galapagos的银屑病药物GSK2586184中期试验达终点

Galapagos与其合作伙伴葛兰素史克称,它们的抗炎候选药物GSK2586184在一项银屑病中期试验中达到终点,对这款命运多桀的药物来说,这是突如其来的好消息。 葛兰素史克称,这款药物在66名患者参与,周期为12周的IIa期研究中达到了改善银屑病严重程度的主要终点,两家公司表示试验中无严重不良事件发生。葛兰素史克正在进行这项安慰剂对照研究,根据2012年两家公司签订的协议,Galapagos很

BMC Oral Health:在北欧人群中中重度银屑病与牙周炎的关系

背景  本研究的目的是将患有银屑病的人群与随机选择的对照人群相比,其发生牙周炎和牙槽骨丧失的患病率。方法   50名银屑病患者和121名对照者完成问卷调查,然后接受临床和影像学检查。口腔检查包括缺失牙的数目、牙周袋探诊深度(PPD)、临床附着水平(CAL)、菌斑指数、探针出血指数以及影像上反应出的牙槽骨丧失水平。问卷要求填写的信息包括年龄、性别、受教育程度、牙齿保健情

Nature:单克隆抗体Tildrakizumab对牛皮癣可能有效

                                              近日,来自奥地利的科学家们在著名国际期刊nature在线发表了他们的最新研

Baidu
map
Baidu
map
Baidu
map